Paper405385
Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.
Abuchowski A and 3 others. J Biol Chem, 1977. Cited by 779 papers, by iCite.
Cite this record
ConductScience Library. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. Papers, record 405385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/405385
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Polyethylene Glycols | Major topic |
| Serum Albumin, Bovine | Major topic |
| Animals | |
| Antibody Formation | |
| Immunodiffusion | |
| Molecular Weight | |
| Rabbits |
Source PubMed
Cited by226
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 779 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42877048 | Chemically modified gelatin derivatives: synthetic strategies, physicochemical properties, biodegradation, drug delivery and biomedical applications. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42877048 | PubMed |
| 42852286 | Impact of Organic Solvents, Surfactants, and Nonfunctionalized PEGs on PEGylation Reaction Yield. | ACS Omega | 2026 | https://conductscience.org/library/papers/42852286 | PubMed |
| 42734265 | Effective Reduction of Anti-PEG Antibody Recognition via PEG Copolymers with Ethyl Glycidyl Ether and Isopropyl Glycidyl Ether. | Biomacromolecules | 2026 | https://conductscience.org/library/papers/42734265 | PubMed |
| 42456079 | Suppressive Immune Response of Poly(sarcosine) Conjugated Proteins: PSARylation. | Bioconjug Chem | 2026 | https://conductscience.org/library/papers/42456079 | PubMed |
| 42438481 | Monodisperse PEG engineering for quantifiable surface conjugation on PLGA nanoparticles. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/42438481 | PubMed |
| 42272180 | Oxygen-Tolerant Photo-Induced Miniaturized Accelerated Atom Transfer Radical Polymerization (OPTIMA-ATRP) for High-Throughput Synthesis of Polymer Bioconjugates. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42272180 | PubMed |
| 41647359 | Regulatory framework for polymer-based nanotherapeutics in clinical translation. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/41647359 | PubMed |
| 41442576 | A Non-Antigenic Randomized Polyethylene Glycol/Poly(2-Phenyl-2-Oxazine)-Based Drug Delivery Platform. | Macromol Rapid Commun | 2026 | https://conductscience.org/library/papers/41442576 | PubMed |
| 41304777 | Comparative Stability of Synthetic and Natural Polymeric Micelles in Physiological Environments: Implications for Drug Delivery. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41304777 | PubMed |
| 41124269 | The evolution of nanomedicine: The rise of next-generation nanomaterials in cancer nanomedicine. | Sci Adv | 2025 | https://conductscience.org/library/papers/41124269 | PubMed |
| 41048377 | Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease. | Clin Exp Gastroenterol | 2025 | https://conductscience.org/library/papers/41048377 | PubMed |
| 40965131 | Distinct functions of cardiac β-adrenergic receptors in the T-tubule vs. outer surface membrane. | Elife | 2025 | https://conductscience.org/library/papers/40965131 | PubMed |
| 40857654 | Biofilm Eradication Using Water-Soluble Silver(I) Coumarin Complexes. | Chembiochem | 2025 | https://conductscience.org/library/papers/40857654 | PubMed |
| 40788220 | PD-L1-Targeting Biomimetic Photoresponsive Thermosensitive Liposomes for Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40788220 | PubMed |
| 40730517 | Considering the immunogenicity of PEG: strategies for overcoming issues with PEGylated nanomedicines. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/40730517 | PubMed |
| 40476701 | pH Controlled Activation and Stabilization of Enzymes Using Responsive Polymer-Bioconjugates. | Biomacromolecules | 2025 | https://conductscience.org/library/papers/40476701 | PubMed |
| 40143042 | Clinical Applications of Targeted Nanomaterials. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40143042 | PubMed |
| 39990937 | Antigenicity Extension: A Novel Concept Explained by the Immunogenicity of PEG. | ACS Bio Med Chem Au | 2025 | https://conductscience.org/library/papers/39990937 | PubMed |
| 39860198 | Fibroin-Hybrid Systems: Current Advances in Biomedical Applications. | Molecules | 2025 | https://conductscience.org/library/papers/39860198 | PubMed |
| 39802382 | Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39802382 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/405385
GET https://conductscience.org/api/papers/v1/405385/cited_by?page=2